“Having access to such experienced and high profile professionals has had a huge impact on my project. Their advice sharpened my business plan significantly and led to progression in the negotiations with VCs, they introduced me to opportunities (both strategic and financial) which I was not aware of, and through their network, I have received important high-profile legal advice (pro-bono). Furthermore, I was invited to contact them on an ongoing basis which equipped me with an essential understanding of the pivotal points in VC investment terms seen from a founder’s perspective.”
Alexander Hovard Sparre-Ulrich, CEO Antag

Enrolled startups

  • Antag Antag
    Antag (Denmark) is working on a promising hormone treatment to fight obesity.

  • Hedia Hedia
    Hedia (Denmark) is a personal diabetes-assistant

    http://www.hedia.dk
  • Immunitrack Immunitrack
    Immunitrack (Denmark) works in the field of immunological molecules such as: the neonatal Fc receptor FcRn and major histocompability molecules (MHC).

    http://www.immunitrack.com
  • Lexplore Lexplore
    Lexplore (Sweden) offers a completely new method for dyslexia screening, enabling early, rapid, reliable and objective identification of children in risk of dyslexia.

    http://www.lexplore.com
  • MedTrace MedTrace
    MedTrace (Denmark) has developed several novel safety features, which combined will revolutionize blood flow imaging in PET.

    http://www.medtrace.dk
  • MonTa BioSciences MonTa BioSciences
    MonTa Biosciences (Denmark) is a start-up biotech Company in the cancer immunotherapy field.

    http://www.montabiosciences.com
  • Orthogenics Orthogenics
    Orthogenics (Norway) is leading in the field of joint replacement diagnostics

    http://www.orthogenics.no/
  • ChildTreat ChildTreat
    ChildTreat (Denmark) has deveolped an innovative pain treatment method for children.

  • Saga Diagnostics Saga Diagnostics
    SAGA Diagnostics (Sweden) is a personalized cancer medicine and disease monitoring company.

    http://sagadiagnostics.com/
  • PanCryos PanCryos
    PanCryos (Denmark) aims to develop a next generation stem cell derived allogenic cell therapy (PanINSULA™) for Type 1 diabetes

PROGRAM

Take Your Ideas Further.

LEARN MOREAPPLY NOW

INQUIRIES

Want To Know More About Us?

GET IN TOUCH

© 2017 Nordic Mentor Network for Entrepreneurship